The idiopathic hypereosinophilic syndrome1'2 is a rare condition in which there is persistent eosinophilia in excess of 1.5 x 109/L, with no demonstrable cause. Two of the most serious complications are endomyocardial fibrosis and thromboembolic disease2. Oral anticoagulation has been recommended, but the optimum range for the international normalized ratio in such patients is not known.
CASE HISTORY
A 69-year-old woman with a history of idiopathic hypereosinophilic syndrome was admitted after collapsing. She was too confused to give a history, but her husband described her rising after unsuccessfully straining at stool, walking a few steps and slumping to the floor. She was taking warfarin 2 mg per day, prednisolone 40 mg per day and ranitidine 150 mg twice a day. On examination she had a flacid paralysis in the lower limbs with absent reflexes; dorsalis pedis and posterior tibial pulses could not be felt and there was decreased capillary return in the lower limbs. Proprioception and temperature sensation could not be assessed. The patient was in no pain. Haemoglobin was 1 1.8 g/dL, platelet count 150 x 109/L and white cell count 9.4 x 109/L with a normal differential. The international normalized ratio was 2.4. Urea and electrolytes were within normal limits and plasma glucose was 12.2 mmol/L. Computed tomographic scanning of the brain and magnetic resonance imaging of the spinal cord revealed no abnormalities.
Clearly, the patient had suffered a catastrophic event and, in view of her deteriorating quality of life over the preceding months, after discussion with her family it was agreed that she would receive palliative therapy only. Twenty-four hours later a demarcation line had appeared across her abdomen, and both legs were blue and cold; the clinical diagnosis was aortic thrombosis or dissection with an anterior spinal artery syndrome. Two days after admission the patient died.
At necropsy, platelet-rich thrombus was seen overlying an ulcerated atheromatous plaque of the aorta, causing total occlusion of the lumen extending from immediately beneath the superior mesenteric artery into the orifices of both renal arteries and distally to a point 2 cm below the inferior The patient had been referred to the haematology service three months before admission because of an eosinophilia of 4.78 x 109/L (normal 0.03-0.40), with degranulation and vacuolation of most of the eosinophils. She had lost about 6 kg in weight over the preceding nine months, and had exhibited increasing disorientation and confusion over the preceding three months. Before admission an echocardiogram revealed mild regurgitation of the aortic, tricuspid and pulmonary valves, mild to moderate mitral regurgitation, and good left ventricular function. She had seen a psychogeriatrician who suggested that she had a dementia, possibly vascular in origin. Computed tomographic scans of the brain, chest, abdomen and pelvis were unremarkable. No parasites, ova or cysts were detected in the stool. The patient had persistent eosinophilia with evidence of end organ damage (cardiac valvular disease and dementia), and no demonstrable cause.
Idiopathic hypereosinophilic syndrome was diagnosed' 2 and prednisolone was started. At a follow-up appointment splinter haemorrhages were noted in her right hand, so warfarin was introduced as prophylaxis against thrombosis. COMMENT Acute aortic thrombosis, which has not previously been reported in the hypereosinophilic syndrome, is seen after trauma, after aortic dissection, in the nephrotic syndrome in both animals3 and man4, in critically ill newborn babies with umbilical artery catheters5 and in patients with malignant disease6'7. The common denominator in these conditions is an increased thrombotic tendency, whether related to disruption of the endothelium or to abnormal levels of clotting factors. In hypereosinophilic conditions thrombosis is hypothesized to be due to inactivation of thrombomodulin by its binding to the eosinophil granule protein, major basic protein8. Thrombomodulin normally provides an anticoagulant function by binding thrombin and factor Xa to create the catalyst that activates plasma protein C to activated protein C. Spry2 notes that thrombosis can occur in the hypereosinophilic syndrome despite antiplatelet treatment and recommends long-term warfarin treatment in patients with evidence of emboli. The patient described here had her international normalized ratio checked on several occasions, and it was consistently in the range 2.0-2.4. In view of her fatal thrombosis, perhaps the range to aim for in hypereosinophilic syndrome should be higher. Isolated thoracic duct injury is uncommon with nonpenetrating trauma. We report such a case.
A 29-year-old woman reported neck pain two weeks after sustaining an extension-flexion injury of the cervical spine in a traffic accident. No abnormalities could be elicited and she was reassured. She returned 3 months later with a painless mass in the left supraclavicular region evident to her for 10 days. A firm nodule 2 cm in diameter was palpable in the supraclavicular triangle, and ultrasound examination showed a partially cystic mass which was thought to be an enlarged lymph node. A fine needle aspiration biopsy showed presence of normal lymphocytes. At open exploration a 1.5 cm cystic lesion was removed. When she began oral intake later the same day, a large amount of milky fluid drained (500 mL in the first 12 hours) and chylous fistula was diagnosed. 
